STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended January 3, 2020. Fourth Quarter 2019 Overview Net Sales of $38.9 Million Up 25% from the Prior Year Quarter ICL Sales of $33.3 Million Up 27% and Units Up 27% from the Prior Year Quarter Gross Margin at 74.1% vs. 73.7% in the Prior